Drug or treatment

Inotuzumab clinical trials

• 13Clinical trials
• 6Countries

Newest trials

All recruiting trials (13)

• Full-course immunotherapy for B‑cell acute lymphoblastic leukemia patients who are unfit for or decline chemotherapy

  This study will try a full course of sequential immunotherapy with blinatumomab followed by inotuzumab ozogamicin for people with B‑cell ALL who are older, unfit for, have relapsed/refractory disease, or who decline intensive chemotherapy.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06985485

• Inotuzumab Ozogamicin + Venetoclax + Dexamethasone (IoVeX) for relapsed B-cell ALL

  This trial will test whether the drug combination Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone (IoVeX) is safe and well tolerated in children and adults with relapsed B-cell acute lymphoblastic leukemia.

  Recruiting Phase 1 Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT06863259

• Combining Blinatumomab and Venetoclax with Inotuzumab Ozogamicin for B-ALL Treatment

  This study is testing a new combination of three medications to see if it can help adults with newly diagnosed B-cell acute lymphoblastic leukemia live longer and healthier lives.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06554626

• Using Brexucabtagene Autoleucel to treat B-cell Acute Lymphoblastic Leukemia after initial therapy

  This study is testing a new CAR-T cell therapy called brexucabtagene autoleucel to see if it can help people with B-cell acute lymphoblastic leukemia who haven't responded to other treatments.

  Recruiting Phase 1/2 M.D. Anderson Cancer Center · Houston, Texas · NCT06287229

• Using Inotuzumab Ozogamicin to treat MRD-positive ALL after stem cell transplant

  This study is testing if a new treatment called Inotuzumab Ozogamicin can help young adults with a type of leukemia who have had a stem cell transplant and are facing a return of their disease.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT05940961

• New treatment approach for pediatric patients with relapsed B-cell leukemia

  This study is testing a new combination treatment for kids with relapsed B-cell leukemia to see if it helps them get better and live longer.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT05645718

• Chemotherapy-free treatment for Ph+ Acute Lymphoblastic Leukemia using Inotuzumab Ozogamicin

  This study is testing if adding a new drug called inotuzumab ozogamicin to standard treatment can help adults with newly diagnosed Ph+ acute lymphoblastic leukemia get better faster and more completely.

  Recruiting Phase 2 University of Chicago · Chicago, Illinois · NCT04747912

• Using inotuzumab ozogamicin with chemotherapy for high-risk B-cell leukemia

  This study is testing if adding a targeted therapy called inotuzumab ozogamicin to standard chemotherapy can help young patients with high-risk B-cell leukemia live longer without their cancer coming back.

  Recruiting at 212 sites Phase 3 Children's Oncology Group · Birmingham, Alabama and 230 other locations · NCT03959085

• Inotuzumab ozogamicin and blinatumomab with optional ponatinib for CD22-positive B-cell acute lymphoblastic leukemia

  This trial will test whether inotuzumab ozogamicin followed by blinatumomab, with or without ponatinib, can help people with CD22-positive B-cell acute lymphoblastic leukemia who are newly diagnosed, have relapsed, or are refractory to prior therapy.

  Recruiting at 89 sites Phase 2 National Cancer Institute (NCI) · Birmingham, Alabama and 284 other locations · NCT03739814

• Inotuzumab ozogamicin with frontline chemotherapy for young adults with B‑cell acute lymphoblastic leukemia

  This trial tests whether adding the antibody-drug inotuzumab ozogamicin to a pediatric-style frontline chemotherapy plan helps young adults with newly diagnosed CD22-positive B acute lymphoblastic leukemia live longer without relapse.

  Recruiting at 157 sites Phase 3 Alliance for Clinical Trials in Oncology · Birmingham, Alabama and 459 other locations · NCT03150693

• Using Inotuzumab Ozogamicin after Stem Cell Transplant for Acute Lymphocytic Leukemia

  This study is testing if a new drug called inotuzumab ozogamicin can help people with acute lymphocytic leukemia who have had a stem cell transplant stay healthy and avoid relapse.

  Recruiting at 4 sites Phase 1/2 Case Comprehensive Cancer Center · Westwood, Kansas and 6 other locations · NCT03104491

• Using blinatumomab, inotuzumab ozogamicin, and chemotherapy to treat B acute lymphoblastic leukemia

  This study is testing a new combination of two immunotherapy drugs and chemotherapy to see if it helps people with newly diagnosed B acute lymphoblastic leukemia live longer and stay cancer-free.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT02877303

• Using inotuzumab ozogamicin with chemotherapy to treat acute lymphoblastic leukemia

  This study is testing if a new drug combined with lighter chemotherapy can help older patients with acute lymphoblastic leukemia who can't handle stronger treatments.

  Recruiting Phase 1/2 M.D. Anderson Cancer Center · Houston, Texas · NCT01371630

Quick answers

How many clinical trials of Inotuzumab are recruiting right now?

13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in United States (10 trials), China (3 trials), Canada (2 trials), Puerto Rico (2 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 7, Phase 1/2: 3, Phase 3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →